HealthyRegular · Option n/aFit for a long SIP
ICICI Prudential Healthcare Fund
ICICI Prudential Mutual FundEquity Schemes - Thematic Fund8.3 years
- NAV
- 42.11
- 29 Oct 2026
- 1Y
- +3.9%
- Trailing CAGR
- AUM
- ₹3,397.83 Cr
- 30 Jun 2026
- Volatility
- Medium
- 15.1% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Pass
8.3 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Watch
2.06% TER on Regular - Direct is usually cheaper for the same scheme.
Drawdown vs peers
Pass
Peak-to-trough -20.7%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Plan class
Watch
Regular plan - switch the buy to Direct Growth of the same scheme when you can.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 21%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
Regular plan drag
Regular TER compounds against you on long SIPs. Prefer the Direct Growth class of the same scheme when you buy.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+3.9%
- 3Y+21.5%
- 5Y+15.7%
- 10Yn/a
- SI+19.1%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+8.0%
- 3Y+11.0%
- 5Y+17.8%
- 10Yn/a
- Since inception
- +19.1%
- Calendar-day CAGR
- Excess 1Y
- n/a
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- +11.0%
- Simulated monthly SIP
- Worst rolling 3Y
- +13.4%
- 1303 daily-ending windows
- Median rolling 3Y
- +23.8%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 810 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -20.7%
- Worst peak-to-trough
- Current
- -4.9%
- Below last peak
- Current spell
- 79 days
- Days below latest peak
- Time below peak
- +88%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 12 days
- 96 recovered episodes
- Longest recovery
- 378 days
- Trough to prior peak
14 Feb 2020 – 9 Apr 2020
Trough 23 Mar 2020 · recovered in 17 days
-20.7%
15 Sept 2021 – 30 Jun 2023
Trough 17 Jun 2022 · recovered in 378 days
-18.7%
7 Sept 2018 – 10 Feb 2020
Trough 7 Oct 2019 · recovered in 126 days
-16.7%
2 Jan 2025 – 15 Jul 2025
Trough 28 Feb 2025 · recovered in 137 days
-16.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
88
Vs category
n/a
Consistency
n/a
Risk-adjusted
68
Drawdown
48
Mean
68
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
No holdings or recent changes on file for this scheme yet.
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Axis Consumption Fund
Axis Mutual Fund
- 1Y
- -10.4%
- 3Y
- n/a
- Vol
- 13.9%
- Max DD
- -20.1%
- Sharpe
- -0.74
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
DSP Business Cycle Fund
DSP Mutual Fund
- 1Y
- -4.0%
- 3Y
- n/a
- Vol
- 13.7%
- Max DD
- -14.8%
- Sharpe
- -0.35
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
UTI Quant Fund
UTI Mutual Fund
- 1Y
- -6.3%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -14.5%
- Sharpe
- -0.29
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
WhiteOak Capital ESG Best-In-Class Strategy Fund
WhiteOak Capital Mutual Fund
- 1Y
- -9.3%
- 3Y
- n/a
- Vol
- 13.2%
- Max DD
- -17.2%
- Sharpe
- -0.41
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns
WhiteOak Capital Quality Equity Fund
WhiteOak Capital Mutual Fund
- 1Y
- -8.2%
- 3Y
- n/a
- Vol
- 12.1%
- Max DD
- -16.4%
- Sharpe
- -0.47
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
Caveat: Lower trailing returns